Is Hydrogen Cyanide a Marker of Burkholderia cepacia Complex?

被引：12

作者：

Gilchrist, Francis J. ^{[1
,2
,4
]}

Sims, Hayley ^{[3
]}

Alcock, Alice ^{[3
]}

Jones, Andrew M. ^{[2
]}

Bright-Thomas, Rowland J. ^{[2
]}

Smith, David ^{[4
]}

Spanel, Patrik ^{[4
,5
]}

Webb, A. Kevin ^{[2
]}

Lenney, Warren ^{[1
,4
]}

机构：

[1] Univ Hosp North Staffordshire, Acad Dept Child Hlth, Stoke On Trent, Staffs, England

[2] Wythenshawe Hosp, Manchester Adult Cyst Fibrosis Ctr, Manchester M23 9LT, Lancs, England

[3] Univ Hosp North Staffordshire, Dept Microbiol, Stoke On Trent, Staffs, England

[4] Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Stoke On Trent, Staffs, England

[5] Acad Sci Czech Republic, J Heyrovsky Inst Phys Chem, Prague, Czech Republic

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2013年 / 51卷 / 11期

关键词：

PSEUDOMONAS-AERUGINOSA;

D O I：

10.1128/JCM.02157-13

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Biofilm cultures of Burkholderia cepacia complex (BCC) infection have been found to generate the nonvolatile cyanide ion. We investigated if gaseous hydrogen cyanide (HCN) was a marker of BCC infection. Selected ion flow tube mass spectrometry analysis showed HCN was not elevated in the headspace of planktonic or biofilm cultures or in the exhaled breath of adult cystic fibrosis patients with chronic BCC infection. HCN is therefore not an in vitro or in vivo marker of BCC.

引用

页码：3849 / 3851

页数：3

共 50 条

[41] Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex
Gingues, S
Kooi, C
Visser, MB
Subsin, B
Sokol, PA
JOURNAL OF BACTERIOLOGY, 2005, 187 (24) : 8247 - 8255
[42] Burkholderia cepacia Complex Taxon K: Where to Split?
Depoorter, Eliza
De Canck, Evelien
Peeters, Charlotte
Wieme, Anneleen D.
Cnockaert, Margo
Zlosnik, James E. A.
LiPuma, John J.
Coenye, Tom
Vandamme, Peter
FRONTIERS IN MICROBIOLOGY, 2020, 11
[43] An epidemic Burkholderia cepacia complex strain identified in soil
LiPuma, JJ
Spilker, T
Coenye, T
Gonzalez, CF
LANCET, 2002, 359 (9322): : 2002 - 2003
[44] Combination aerosol therapy to treat Burkholderia cepacia complex
Middleton, PG
Kidd, TJ
Williams, B
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (02) : 305 - 308
[45] In vitro activity of ceragenins against Burkholderia cepacia complex
Elif Sena Demir
Ozlem Oyardi
Paul B. Savage
Havva Ozlem Altay
Cagla Bozkurt-Guzel
The Journal of Antibiotics, 2022, 75 : 403 - 409
[46] Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides
De Soyza, Anthony
Silipo, Alba
Lanzetta, Rosa
Govan, John R.
Molinaro, Antonio
INNATE IMMUNITY, 2008, 14 (03) : 127 - 144
[47] Environmental Burkholderia cepacia complex isolates in human infections
Baldwin, Adam
Mahenthiralingam, Eshwar
Drevinek, Pavel
Vandamme, Peter
Govan, John R.
Waine, David J.
LiPuma, John J.
Chiarini, Luigi
Dalmastri, Claudia
Henry, Deborah A.
Speert, David P.
Honeybourne, David
Maiden, Martin C. J.
Dowson, Chris G.
EMERGING INFECTIOUS DISEASES, 2007, 13 (03) : 458 - 461
[48] Approaches to measure the fitness of Burkholderia cepacia complex isolates
Pope, C. F.
Gillespie, S. H.
Moore, J. E.
McHugh, T. D.
JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (06) : 679 - 686
[49] Isolation of Burkholderia cepacia complex genomovars from waters
Vermis, K
Brachkova, M
Vandamme, P
Nelis, H
SYSTEMATIC AND APPLIED MICROBIOLOGY, 2003, 26 (04) : 595 - 600
[50] Species abundance and diversity of Burkholderia cepacia complex in the environment
Ramette, A
LiPuma, JJ
Tiedje, JM
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (03) : 1193 - 1201

← 1 2 3 4 5 →